Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders.
Modulight Bio has raised $12.0M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Modulight Bio's investors include Sha'ar Mivnim, LocalGlobe, Redseed, Jibe Ventures, Nexus NeuroTech.
Modulight Bio is headquartered in Boston, United States.
Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders.
Modulight Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Modulight Bio — Funding & Investors." VCBacked, November 13, 2025, https://www.vcbacked.co/company/modulight-bio. Accessed July 21, 2026.
VCBacked. (2025). Modulight Bio — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/modulight-bio
{{cite web |title=Modulight Bio — Funding & Investors |url=https://www.vcbacked.co/company/modulight-bio |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated